Drug · DIN 02415674
GIOTRIF
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since January 17, 2014; first marketed January 17, 2014.
- Drug Identification Number (DIN)
- 02415674
- Company (DIN owner)
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Afatinib L01EB03
- Class
- Human
- Record last updated
- June 16, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| AFATINIB (AFATINIB DIMALEATE) | 30 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 1, 2013: NOC 14873New Drug Submission (NDS)
Other DINs named GIOTRIF
- DIN 02415666 · Marketed
- DIN 02415682 · Marketed